Reploid unit HEROSAN launches Invesdor crowdfunding bonds with 9% annual coupon, targets up to € 1.5 million

• Reploid affiliate HEROSAN launched a crowdfunding campaign on Invesdor, offering Anleihen paying a 9% fixed annual coupon over five years.
• Deal targets up to EUR 1.5 million, with investments starting at EUR 250; proceeds earmarked for growth, including product development, marketing, e-commerce.
• HEROSAN reported H1 2026 revenue of EUR 2.3 million, up 64% year on year, following Reploid’s investment in autumn 2025.
• Reploid lifted its stake from 34% to more than 50%, positioning HEROSAN as a key outlet for its insect protein and Vitus mycelium.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reploid Group AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2395762_de) on September 08, 2026, and is solely responsible for the information contained therein.